The UL Hospitals Group is standing over measures that have been implemented in a bid to tackle Superbugs.
It comes after claims from a whistleblower prompted officials to acknowledge the issue with superbugs locally, and how one has been a contributory factor in three deaths here.
The UL Hospitals Group is reassuring patients that measures have been implemented to prevent the spread of potentially life-threatening Superbugs at the region's main hospital.
A whistleblower had claimed that 29 people died between 2012 and 2014, after they contracted the CRE bug.
The hospital has refuted these claims saying that while there 92 cases and 27 CRE-related deaths over a six year period from 2009, the bug was only a contributory factor in 3 of these.
In 2014, HIQA raised concerns over infection controls at Dooradoyle but since then a number of measures have been implemented including refurbishment of in-patient wards and the introduction of deep cleaning measures.
Clinical Director of UL Hospitals Group, Paul Burke says he's confident that enough is being done by the hospital to ensure patients don't contract drug resistant infections.
At the moment, patients who contract bugs are placed in an isolation unit, but the hospital admits this isn't ideal and that there are issues with the infrastructure there.
An application has been made for funding to build a new 96 single-bedded unit, which is expected to cost around 40 million euro, but no decision has been made on whether this will be given the green light.
Chairman of the HSE's Regional Health Forum West Tom McNamara says increased funding is needed to ensure that University Hospital Limerick is up to standard.
